Design, synthesis, and biological evaluation of 1,6-naphthyridine-2-one derivatives as novel FGFR4 inhibitors for the treatment of colorectal cancer.
Fang B, Lai Y, Yan H, Ma Y, Ni Z, Zhu Q, Zhang J, Ye Y, Wang M, Wang P, Wang Y, Zhang S, Hui M, Wang D, Zhao Y, Li X, Wang K, Liu Z.
Fang B, et al. Among authors: wang k, wang y, wang p, wang m, wang d.
Eur J Med Chem. 2023 Nov 5;259:115703. doi: 10.1016/j.ejmech.2023.115703. Epub 2023 Aug 4.
Eur J Med Chem. 2023.
PMID: 37556948